We are live on ! Find out more
WVP

Worth Venture Partners Portfolio holdings

AUM $31.6M
1-Year Est. Return 28.5%
This Fund
S&P 500
This Quarter Est. Return
+3.3%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$181M
AUM Growth
+$1.1M
Cap. Flow
-$73.9M
Cap. Flow %
-40.89%
Top 10 Hldgs %
71.68%
Holding
125
New
27
Increased
27
Reduced
16
Closed
30

Top Buys

Rank Stock Value
1
COHR
Coherent Inc
COHR
+$2.5M
2
AVTR.PRA
Avantor, Inc. Series A Mandatory Convertible Preferred Stock
AVTR.PRA
+$1.86M
3
DZSI
DZS Inc. Common Stock
DZSI
+$1.79M
4
MU icon
Micron Technology
MU
+$1.09M
5
ASPN icon
Aspen Aerogels
ASPN
+$943K

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$3.73M
2
AMGN icon
Amgen
AMGN
+$2.25M
3
AMSC icon
American Superconductor
AMSC
+$1.34M
4
QCOM icon
Qualcomm
QCOM
+$876K
5
RIG icon
Transocean
RIG
+$635K

Sector Composition

Rank Sector Weight
1 Technology 7.59%
2 Healthcare 5.46%
3 Industrials 2.4%
4 Consumer Discretionary 0.95%
5 Communication Services 0.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AGX icon
51
Argan
AGX
$7.33B
$232K 0.13%
+3,343
New +$157K
TTGT icon
52
TechTarget
TTGT
$323M
$223K 0.12%
+10,490
New +$196K
BNGO icon
53
Bionano Genomics
BNGO
$12.5M
$215K 0.12%
146
– –
LJPC
54
DELISTED
La Jolla Pharmaceutical Company
LJPC
$204K 0.11%
22,000
-73,607
-77% -$555K
IZEA icon
55
IZEA Worldwide
IZEA
$60.4M
$193K 0.11%
+94,270
New +$289K
DRRX
56
DELISTED
DURECT Corp
DRRX
$172K 0.1%
+26,412
New +$165K
XLNX
57
CALL
DELISTED
Xilinx Inc
XLNX
$169K 0.09%
30,000
-12,500
-29% -$1.46M
ACHV icon
58
Achieve Life Sciences
ACHV
$634M
$139K 0.08%
3,589
-2,594
-42% -$183K
ATEX icon
59
Anterix
ATEX
$1.78B
$107K 0.06%
2,257
-106
-4% -$4.48K
SRDX
60
CALL
DELISTED
Surmodics
SRDX
$106K 0.06%
+23,300
New +$984K
XLC icon
61
State Street Communication Services Select Sector SPDR ETF
XLC
$22.6B
$102K 0.06%
+2,064
New +$100K
ITCI
62
CALL
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$99K 0.05%
51,200
-16,300
-24% -$209K
ONCS
63
DELISTED
OncoSec Medical Incorporated
ONCS
$99K 0.05%
+1,784
New +$172K
ICAD
64
DELISTED
iCAD Inc
ICAD
$92K 0.05%
+14,358
New +$82K
XLB icon
65
State Street Materials Select Sector SPDR ETF
XLB
$8.82B
$84K 0.05%
+2,870
New +$81K
XLRE icon
66
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.73B
$79K 0.04%
+2,167
New +$79.2K
XLU icon
67
State Street Utilities Select Sector SPDR ETF
XLU
$23.4B
$79K 0.04%
2,644
+624
+31% +$18.3K
BNGOW
68
DELISTED
Bionano Genomics, Inc. Warrant
BNGOW
$65K 0.04%
88,446
– –
FEED
69
ENvue Medical Inc
FEED
$2.09M
$58K 0.03%
9
– –
FOMX
70
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$56K 0.03%
23,627
+10,127
+75% +$30.3K
ENTX icon
71
Entera Bio
ENTX
$161M
$49K 0.03%
16,012
+1,063
+7% +$4.13K
BKNG icon
72
PUT
Booking.com
BKNG
$154B
$30K 0.02%
25,000
+19,800
+381% +$1.42M
XLE icon
73
State Street Energy Select Sector SPDR ETF
XLE
$38.3B
$20K 0.01%
+642
New +$20.6K
TDG icon
74
PUT
TransDigm Group
TDG
$73.2B
$19K 0.01%
+7,485
New +$3.5M
GCVRZ
75
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$15K 0.01%
28,979
– –
1 2
3
4 5

Similar funds

VL
Vorpal LLC Nashville, Tennessee $32M AUM 10.89% 1-Year Est. Return
WTG
West Tower Group Richmond, Virginia $32.1M AUM 33.19% 1-Year Est. Return
QCA
Quantify Chaos Advisors Brooklyn, New York $32.1M AUM
SP
SCF Partners Houston, Texas $32.2M AUM 191.71% 1-Year Est. Return
OGC
One68 Global Capital New York $30.9M AUM
PE
Platinum Equity Beverly Hills, California $32.3M AUM 17.64% 1-Year Est. Return
RL
RPO LLC Stamford, Connecticut $32.3M AUM 14.17% 1-Year Est. Return
AIIC
AJU IB Investment Company Seoul, South Korea $30.5M AUM 128.96% 1-Year Est. Return

Worth Venture Partners's Q2 2019 Portfolio in Review

As of Q2 2019, Worth Venture Partners held 125 positions worth $181M, up 0.61% from $180M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

Worth Venture Partners withdrew a net $73.9M in Q2 2019, closing 30 positions and reducing 16 holdings. Its most notable exit was Biogen, an estimated $3.73M position sold in full.

By sector, the portfolio is most concentrated in Technology at 7.6% of assets, up from 5.7% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Worth Venture Partners opened a new position in Coherent Inc worth $2.53M.

  • Worth Venture Partners's largest Q2 2019 buy was Coherent Inc: 18,524 shares worth $2.53M.
  • Worth Venture Partners added most to QuickLogic in Q2 2019, an estimated $726K increase.
  • Worth Venture Partners's biggest Q2 2019 reduction was Nano Dimension, cutting an estimated $582K.
  • Worth Venture Partners fully exited Biogen in Q2 2019, selling an estimated $3.73M.
  • Worth Venture Partners's ten largest holdings make up 72% of its $181M portfolio in Q2 2019.
  • Worth Venture Partners opened 27 new positions and closed 30 in Q2 2019.
  • Worth Venture Partners's portfolio value rose 0.61% quarter-over-quarter to $181M.

Based on Worth Venture Partners's 13F filing for Q2 2019, filed 14 Aug 2019.